ABS Direct Equity Fund LLC
Source: SEC Form 13F · as of Mar 2026ABS Direct Equity Fund LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $3.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$3.9M
| Company | Shares | Value |
|---|---|---|
| SHCSotera Health Company | 50,000 | $717K |
| RVMDREVOLUTION MEDICINES, INC. | 1,800 | $266K |
| MIRMMirum Pharmaceuticals, Inc. | 2,100 | $222K |
| GHGuardant Health Inc. | 2,300 | $210K |
| ICLRICON plc | 1,800 | $202K |
| LLYELI LILLY & Co | 200 | $194K |
| SYRESpyre Therapeutics, Inc. | 2,800 | $194K |
| JAZZJazz Pharmaceuticals plc | 900 | $187K |
| RPRXRoyalty Pharma plc | 3,600 | $181K |
| DNTHDianthus Therapeutics, Inc. /DE/ | 2,000 | $179K |
| CGONCG Oncology, Inc. | 2,600 | $176K |
| COGTCogent Biosciences, Inc. | 4,700 | $173K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1,000 | $172K |
| ALKSAlkermes plc. | 4,900 | $167K |
| RNTXRein Therapeutics, Inc. | 125,000 | $163K |
| GEHCGE HealthCare Technologies Inc. | 2,400 | $146K |
| ACTUACTUATE THERAPEUTICS, INC. | 50,000 | $137K |
| PRAXPraxis Precision Medicines, Inc. | 400 | $135K |
| BBIOBridgeBio Pharma, Inc. | 1,243 | $86K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.